| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.008 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.008 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.009 |